Opsy Competitors and Similar CompaniesClear all
Opsy's competitors and similar companies include Mallinckrodt Pharmaceuticals.
 Opsy Opsy Holding (formerly WntResearch) is a biotech company that develops therapies for preventing cancer spread. |  Mallinckrodt Pharmaceuticals Mallinckrodt is a business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies. | |
Founding Date | Founding Date 2007 | Founding Date 1867 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Gothenburg, SE HQ Lund, SE | Locations Dublin 15, IE HQ Staines, GB Hazelwood, US Webster Groves, US |
Employees | Employees 2 | Employees 3,373 |
Financial | ||
Revenue (est.) | Revenue (est.) kr6.7m (FY, 2025) | Revenue (est.) $1b (FY, 2022) |
Cost of goods | Cost of goods kr1.3m (FY, 2025) | Cost of goods $643.5m (FY, 2022) |
Gross profit | Gross profit kr5.4m (FY, 2025) | Gross profit $396.2m (FY, 2022) |
Net income | Net income (kr17.2m) (FY, 2025) | Net income ($598.3m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Mallinckrodt Pharmaceuticals
HQ
Dublin 15, IE
Employees
3,373
Mallinckrodt is a business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies.
View company